HK · Healthcare

HUTCHMED China Ltd (0013)

Drug Manufacturers - Specialty & Generic

HUTCHMED China Ltd (0013) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $16.39B, P/E ratio is 4.59, net margin is 83.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 0013

Market cap

$16.39B

P/E ratio

4.59

Gross profit (TTM)

$63.87M

Net margin

83.3%

HUTCHMED China Ltd (0013) — FAQ

What is HUTCHMED China Ltd's market cap?

HUTCHMED China Ltd (0013) has a reported market cap of $16.39B (data as of 2026-05-21).

What is 0013's P/E ratio?

The price-to-earnings (P/E) ratio for HUTCHMED China Ltd (0013) is 4.59 (data as of 2026-05-21).

Does HUTCHMED China Ltd pay a dividend?

Dividend yield is not available in the current snapshot for HUTCHMED China Ltd (0013). Check the MyAverix Finance app for the latest dividend data.

What sector is HUTCHMED China Ltd in?

HUTCHMED China Ltd (0013) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 0013 listed on?

0013 is listed on HK.

What is HUTCHMED China Ltd's net margin?

HUTCHMED China Ltd (0013) reports a net margin of 83.3% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)